Back to search results

Connecting Research Data for Cancer and Benign Tumors

This study aims to connect research data from different studies you might participate in at the Developmental Therapeutics Clinic (DTC) at the NIH Clinical Center. If you are being evaluated or treated for cancer or benign tumors at the DTC, you might be eligible. The study doesn't involve new treatments or tests. Instead, it helps researchers link information from your tissue or fluid samples and medical records across various studies. This allows them to better understand how your cancer responds to different drugs over time. The main goal is to get your permission to link this data. This is an observational study, meaning researchers will collect information without giving you any specific interventions. The study is currently unclear on its recruitment status.

Study design
This is an observational study planning to enroll up to 3000 participants. It is not a randomized or blinded study.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03269578

Sample Collection and Tracking for the Developmental Therapeutics Clinic

Recruiting
Not specifiedAges 18+Observational
National Cancer Institute (NCI)
~3,000 participants
Updated 2026-08-17 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Obtaining informed consent
Measured over Time of enrollment

Conditions

Neoplasms
Lymphoma

Explore related trials

LymphomaNeoplasm

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Alice P Chen, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)

Who to contact

Jennifer H Zlott
[email protected]
(240) 760-6046
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who are being evaluated and/or treated for cancer or benign tuumors in the Developmental Therapeutics Clinic at the NIH Clinical Center
Ability to understand and willingness to sign a written informed consent document indicating their willingness to have data from their tissue or biologic fluid research specimens and limited medial information used for research as outlined in this protocol and to allow protocol staff access to the CRIS database and their Medical Records Number (MRN).
Age greater than or equal to 18 years

What this trial measures

  • Obtaining informed consentTime of enrollment

    Collation of research sample and treatment data from individual patients across their participation in consecutive DTC clinical trials